My Companies
Notification
Account
First of four peptide manufacturing modules commenced operations with 7000L reactor capacity (750L SPPS, 6250L LPPS) after $30M investment; Module 2 up to 18000L to start ahead of schedule with anchor customer finalising configuration as demand broadens beyond obesity to oncology.
No events have occurred recently